Five Prime Therapeutics (FPRX) Surges: Stock Moves 22.6% Higher - Tale of the Tape
March 18 2014 - 9:18AM
Zacks
Five Prime Therapeutics, Inc.
(FPRX) was a big mover last session, as the company saw its shares
rise by roughly 23% on the day. The move came on solid volume too
with far more shares changing hands than in a normal session.
This continues the recent uptrend of the company as the stock has
now gained almost 67% since Mar 3.
This biotechnology company has seen no estimate revision over the
last 30 days while its Zacks Consensus Estimate moved higher over
the same time frame, suggesting that more solid trading could be
ahead for Five Prime Therapeutics. So make sure to keep an eye on
this stock going forward to see if this recent move higher can turn
into more strength down the road.
Five Prime Therapeutics has a Zacks Rank #3 (Hold) while its
Earnings ESP is 0.00%.
Some better-ranked stocks in the industrial goods sector include
Alkermes plc (ALKS), Alexion
Pharmaceuticals, Inc. (ALXN) and ANI
Pharmaceuticals, Inc. (ANIP). All these stocks hold
a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days.Click to get this free report >>
ALKERMES INC (ALKS): Free Stock Analysis Report
ALEXION PHARMA (ALXN): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
FIVEPRIME THERA (FPRX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Apr 2024 to May 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From May 2023 to May 2024